Received Feb 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | UNK | — |
did not come back to receive the third dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (received 1st dose on an unknown date) and Twinrix (2nd dose in September 2024). On an unknown date, the patient did not receive the 3rd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced incomplete course of vaccination (Verbatim: did not come back to receive the third dose). The outcome of the incomplete course of vaccination was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 15-JAN-2025 The patient received first dose and second dose of Twinrix on time according to accelerated schedule (0, 7 days, 21 to 30 days, and 12 months), but they did not come back to receive the third dose that supposed to be given in October 2024, and it was January 2025 now. Till the time of reporting the patient had not received the third dose of Twinrix, which led to incomplete course of vaccination. The reporter did not had any patient demographics, and did not know why it was indicated for this patient to have an accelerated schedule. The reporter did not consent to follow-up.